Xiaodan Sun

Title: Innovations of Xiaodan Sun in Cancer Treatment

Introduction

Xiaodan Sun is a notable inventor based in Dalian, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the synthesis and application of cyclin-dependent protein kinases (Cdks) inhibitors, which are crucial in the fight against cancer.

Latest Patents

Xiaodan Sun holds a patent for a series of cyclin-dependent protein kinases (Cdks) inhibitors, specifically flavonoid organic amine derivatives. The patent outlines a preparation method that involves using Baicalein (or Wogonin) as a lead compound, mixing it with formaldehyde solution and organic amine compounds in a specific molar ratio. The process includes adding methanol, reacting at controlled temperatures, and filtering to obtain a high-purity product. This innovative approach has shown a remarkable increase in the activity of the derivatives, which can selectively induce apoptosis in proliferative phase cancer cells while having minimal impact on normal cells. The product is expected to serve as an effective and low-toxicity anti-cancer drug.

Career Highlights

Throughout his career, Xiaodan Sun has demonstrated a commitment to advancing cancer treatment through his research. His innovative methods and findings have positioned him as a key figure in the development of new therapeutic options for patients. His work not only contributes to scientific knowledge but also has the potential to improve patient outcomes significantly.

Collaborations

Xiaodan Sun has collaborated with notable colleagues, including Shixuan Zhang and Yongming Bao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective research efforts.

Conclusion

Xiaodan Sun's contributions to the field of cancer treatment through his innovative patents and collaborative efforts highlight the importance of research in developing effective therapies. His work exemplifies the potential of scientific innovation to transform healthcare and improve the lives of patients battling cancer.